Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Equity Income: 2018-2022

Historic Equity Income for Arcturus Therapeutics Holdings (ARCT) over the last 5 years, with Dec 2022 value amounting to -$515,000.

  • Arcturus Therapeutics Holdings' Equity Income rose 60.06% to -$131,000 in Q2 2022 from the same period last year, while for Jun 2022 it was -$920,000, marking a year-over-year decrease of 240.03%. This contributed to the annual value of -$515,000 for FY2022, which is 200.00% down from last year.
  • As of FY2022, Arcturus Therapeutics Holdings' Equity Income stood at -$515,000, which was down 200.00% from $515,000 recorded in FY2021.
  • In the past 5 years, Arcturus Therapeutics Holdings' Equity Income registered a high of $515,000 during FY2021, and its lowest value of -$515,000 during FY2022.
  • In the last 3 years, Arcturus Therapeutics Holdings' Equity Income had a median value of -$263,000 in 2020 and averaged -$87,667.
  • Per our database at Business Quant, Arcturus Therapeutics Holdings' Equity Income crashed by 721.88% in 2020 and then spiked by 295.82% in 2021.
  • Arcturus Therapeutics Holdings' Equity Income (Yearly) stood at -$302,000 in 2018, then spiked by 89.40% to -$32,000 in 2019, then crashed by 721.88% to -$263,000 in 2020, then skyrocketed by 295.82% to $515,000 in 2021, then plummeted by 200.00% to -$515,000 in 2022.